Mycobacterium tuberculosis (Mtb), the pathogen causing human tuberculosis, has evolved multiple strategies to successfully prevent clearance by immune cells and to establish dissemination and long-term survival in the host. The modulation of host immunity to maximize pathogen elimination while minimizing inflammation-mediated tissue damage may provide another tool to fight drug-resistant Mtb strains.
Introduction
Protective immunity of host cells during their infection by bacterial pathogens includes a broad variety of pathways and spatially regulated molecular players. Although the interplay between mechanisms of antimicrobial resistance and adapted tolerance of inflammatory responses is able to control infection, e.g. in the lung (Meunier et al. 2017) , several pathogens have evolved strategies to resist host defense and to persist for long time periods (Escoll & Buchrieser 2019) . Mycobacterium tuberculosis (Mtb), responsible for tuberculosis (TB) in humans, is transmitted by aerosol droplets followed by engulfment by alveolar macrophages and dendritic cells (DCs) in the lung. Mtb is able to evade different innate antimicrobial mechanisms of host cells and replicates intracellularly (Philips & Ernst 2012) . In addition, host adaptive immune responses are activated and slow down mycobacterial growth, but Mtb infection can also lead to chronic forms of TB. Therefore, TB remains the most common infectious cause of death worldwide, responsible for an estimated 1.3 million deaths each year, together with a dramatic increase in the emergence of multidrug-and extensively drug-resistant Mtb strains (WHO, Global TB Report 2018) . While any organ in the body can be affected by Mtb infection, new infectious cycles are induced by transmission of pulmonary forms of the disease (Cadena & Fortune 2017) . Bacillus Calmette-Guérin (BCG) is the only available vaccine against TB, but is not sufficiently successful in preventing active TB (Kaufmann et al. 2018) . Currently, several novel vaccine candidates are at different stages of clinical trial development in addition to adjuvant strategies and mechanisms to boost current TB vaccines and antibiotics (Andersen & Scriba 2019) . They are at early stages of development and thus require improved understanding of the mechanisms that mediate subversion of host immunity and would help to control the disease.
In recent years, novel host-directed therapies (HDTs) against TB are in development that support elimination of mycobacteria by the host while reducing tissue damage induced by the infection, which have an impact on TB morbidity and mortality . Advances in the understanding of immunometabolism shed light on the intimate link between metabolic states of immune cells and their specific functions during infection and inflammation (Escoll & Buchrieser 2019) and are increasingly applied to improve HDTs against different infectious diseases, including TB (Russell et al. 2019; Shi et al. 2019 ).
The Mtb-infected host cell microenvironment is characterized by dysregulated immunoregulation pathways, for example, Th1/Th17 versus Th2 balance, regulatory T and suppressive myeloid cell populations and a shift from M1-like to M2-like polarized macrophages (Jayashankar & Hafner 2016) . Recent studies have shown that changes in specific host metabolites can be mapped to cellular effector mechanisms and drive different inflammatory phenotypes of immune cells (O'Neill & Pearce 2016) . Itaconate, a host metabolite that is only produced by different immune cell populations upon pro-inflammatory stimuli, such as LPS and type I and II interferons, received increasing attention in recent years (O'Neill & Artyomov 2019) . Itaconate is generated from cis-aconitate in the tricarboxylic acid (TCA) cycle by the catalytic enzyme immuneresponsive gene 1 (IRG1), also known as aconitate decarboxylase 1 (ACOD1) (Michelucci et al. 2013 ). It has previously been shown that itaconate has antimicrobial activity by inhibiting isocitrate lyase (McKinney et al. 2000) , an enzyme of the glyoxylate shunt, which is present in most prokaryotes but absent in mammals. Persistence of Mtb infection requires isocitrate lyase (McKinney et al. 2000) , and recent findings showed that itaconate also plays an immunoregulatory role in macrophages, e.g. by inhibiting succinate dehydrogenase (Lampropoulou et al. 2016) , regulating Nrf2 activity (Mills et al. 2018) and modulating electrophilic stress responses (Bambouskova et al. 2018) . In turn, those activities are able to influence hostpathogen interactions, as it was shown in macrophages during Legionella pneumophila infection (Naujoks et al. 2016; Price et al. 2019 ). More recently, Nair et al. showed that IRG1-deficient mice are highly susceptible to Mtb infection, while no aberrant phenotypes were found during influenza A virus or Listeria monocytogenes infection (Nair et al. 2018) . Their findings suggest that IRG1 expression in myeloid cells shape immunometabolic host responses by regulating neutrophil-dependent inflammation during Mtb infection of the lung. However, the underlying intracellular activities of Mtb-infected immune cells and their contribution to the observed phenotype remained unknown.
Here, we show that IRG1 is induced upon Mtb infection and is directly recruited to Mtb-containing phagosomes. IRG1-deficient phagocytes showed elevated Mtb infection rate and increased Mtb growth in comparison to WT cells resulting in increased mycobacterial numbers in vitro after 4 days post-infection. These observations are accompanied by findings that demonstrate that IRG1-deficient macrophages and DCs have increased levels of lipid droplets, which are reservoirs of host nutrients for Mtb. Similar to the previous report using aerosol infection with the Mtb Erdman strain (Nair et al. 2019) , we found that intranasal inoculation of IRG1-deficient mice by Mtb H37Rv induced severe lung immunopathology and mortality of infected mice. Exacerbated inflammation and high mycobacterial burden in the lungs of Mtb-infected, IRG1-deficient mice was accompanied by large areas of necrotizing granuloma formation, neutrophil infiltration and a pronounced reduction in the number of B and T lymphocytes. Importantly, exposure of IRG1-deficient mice to M. bovis BCG via the intranasal route induced neither lethality nor severe lung immunopathology demonstrating that the phenotype observed in Mtb-infected mice is linked to pathogenic virulence.
Therefore, our findings demonstrate that IRG1 is a major player in controlling the acute phase of Mtb infection.
Results
To evaluate the possible contribution of IRG1 during Mtb infection in vitro, we first established the Irg1 gene expression profile of bone marrow-derived macrophages (BMDMs) infected by the virulent Mtb H37Rv strain using quantitative RT-PCR. While Irg1 was not expressed in resting, non-infected BMDMs, stimulation of cells with LPS (100 ng/ml) and IFN (20 ng/ml) for 24 h induced Irg1 expression considerably ( Figure 1A) , in accordance with previous observations (Lampropoulou et al. 2016) . Infection by Mtb (MOI = 1) also rapidly induced Irg1 expression in BMDMs and showed increased levels between 2 h and 48 h post-infection (hpi), with almost undetectable levels at 96 hpi, comparable to non-infected cells (Figure 1A) .
Full absence of Irg1 signal in BMDMs obtained from IRG1-deficient mice (IRG1 -/-) showed the high specificity of the RT-PCR approach (Figure 1A) . In accordance, the IRG1 protein was upregulated, as detected by western blotting, in lysates of LPS-stimulated or Mtb-infected BMDMs (Figure 1B) . LPS stimulation induced the expression of IRG1 at 6 h and was found at higher levels at 24 h and 48 h after LPS stimulation. Infection of BMDM by Mtb induced a comparable profile of IRG1 expression, detectable between 6 h and 48 h post-infection. In both cases, IRG1 was absent in cell lysates at 96 h (Figure 1B) , in accordance with the results generated by quantitative RT-PCR. In addition to BMDMs, LPS stimulation also induced IRG1 expression in bone marrow-derived dendritic cells (BMDCs), as detected in total cell lysates (TCL) from resting versus LPS-stimulated BMDCs (Figure 1C) .
Intracellular pathogens, such as Mtb, that enter immune cells by phagocytosis, are located in phagosomes, which further interact with endosomal compartments during phagosome maturation. In a previous study, using a well-established phagocytosis model system of antigen-coupled beads (Hoffmann et al. 2012) , we identified by quantitative mass spectrometry the specific recruitment of IRG1 to phagosomes of LPS-stimulated BMDCs (Pauwels et al. 2019) . We confirmed this observation by western blotting analyzing purified latex bead-containing phagosomes (LBP). We found IRG1 present in LBP lysates of LPS-stimulated BMDCs, while it was absent in phagosomal lysates of resting BMDCs (Figure 1C) . In contrast, lysosome-associated membrane protein 1 (LAMP-1), a membrane glycoprotein originated from late endosomes and lysosomes, was recruited to LBPs of both, resting and LPS-stimulated BMDCs ( Figure   1C ). In addition, previous work on macrophage infection by Legionella pneumophila showed that IRG1 could also be recruited to Legionella-containing phagosomes (Naujoks et al. 2016) . Therefore, we examined a possible association of IRG1 with Mtb-containing phagosomes. Mtb-infected BMDMs were fixed 24 hpi and labeled for IRG1, F-actin and nuclei for analysis by confocal microscopy (Figure 1D ). IRG1 was found recruited to Mtb-containing phagosomes, as several IRG1 signals (green) co-localized with Mtb signals (red) (insets in Figure 1D ). In other parts of the cell, IRG1 remained located outside of phagosomes restricted to other cell organelles, such as mitochondria, as demonstrated previously for pro-inflammatory conditions (Tallam et al. 2016) . These findings demonstrated that IRG1 is induced upon Mtb infection, followed by its recruitment to Mtb-containing phagosomes, suggesting a role of IRG1 in the intracellular host defense against mycobacteria.
To further study the characteristics of IRG1 during Mtb infection, we infected BMDMs and BMDCs derived from WT mice or IRG1 -/mice with a GFP-expressing Mtb H37Rv strain and followed colonization of host cells and Mtb replication during 96 h. Cells were grown in 384-well plates and their nuclei were labeled to enable analysis by an automated confocal microscopy approach using in-house multiparametric imaging that allowed acquisition and examination of hundreds of images generating robust and reproducible data sets . Algorithms were applied to input images, which resulted in segmentation of the different fluorescent signals allowing nuclei detection, cell and bacteria selection and further downstream analysis to determine infection rate and number of bacteria per cell (Figure 2A) . First, we observed that the efficacy of Mtb uptake by WT and IRG1 -/phagocytes were comparable, as determined by the percentages of Mtb-infected BMDMs and BMDCs at 2 hpi ( Figure 2B) . We then compared the Mtb intracellular area per infected cell, which directly correlates with the number of Mtb per cell (Queval et al. 2016) , which showed no differences between WT and IRG1 -/-BMDMs and BMDCs at 2 hpi ( Figure 2C) . In contrast, at 96 hpi the percentages of Mtb-infected BMDMs and BMDCs were largely increased in IRG1 -/-BMDMs and BMDCs (Figure 2B) , showing that IRG1 deficiency favors survival and/or intracellular growth of Mtb. This was further supported by the fact that at 96 hpi IRG1-deficient BMDMs and BMDCs also had significantly higher Mtb numbers per cell compared to WT phagocytes (Figure 2C) . These findings indicate that the expression of IRG1, induced by Mtb infection, and the presence of IRG1 during the course of infection enable host cells to restrict excessive growth and replication of Mtb.
A key regulator of host immunity to intracellular bacterial pathogens, including Mtb (Braverman et al. 2016) , is hypoxia inducible factor 1 (HIF1), which controls inflammatory and antimicrobial responses during infection (Knight & Stanley 2019) . HIF1 protein levels are regulated by oxygen and in response to fluctuating metabolite levels (Koivunen et al. 2007) , which activate and stabilize HIF1 leading to the expression of inflammatory cytokines, such as IL-1 (Tannahill et al. 2013) . Based on these facts, we investigated a possible impact of IRG1 activity and itaconate production on the regulation and activity of HIF1 and IL-1, which might influence the intracellular replication of Mtb. We quantified the expression of transcription was detected in both, WT and IRG1 -/-BMDMs. Transcription of Il1b was at the detection limit in non-infected cells (Figure S1B) . After 48 h, LPS and IFN stimulation induced substantial Il1b transcription in WT BMDMs. Although IRG1 -/-BMDMs also upregulated this cytokine, they were less prone to express it compared to WT cells. In the case of Mtb infection, even though at 48 hpi comparable transcription of Il1b was detected in WT and IRG1 -/-BMDMs, at 24 hpi such transcription was only detectable in WT cells, suggesting a delayed inflammatory response to Mtb infection in this cell type. In parallel, we quantified in culture supernatants the secretion of pro-inflammatory cytokines by WT and IRG1 -/-BMDMs at different time points post-infection. Mtb infection of BMDMs induced secretion of IL-1, IL-1, IL-6, MCP-1 (CCL2) and TNF compared to non-infected control cells (Figure S1C) . Levels of IL-1, IL-1 and IL-6 increased during the course of infection, in particular for WT cells, while levels of MCP-1 and TNF were lower at later infection time points (48 hpi and 96 hpi) compared to an earlier time point (24 hpi).
Although we observed a net tendency of impaired secretion of IL-1 and IL-1 by IRG1 -/-BMDMs, the differences between WT and IRG1 -/cells were not statistically significant. Finally, we also applied an imaging approach on BMDMs grown and infected in 384-well plates, using automated confocal microscopy and multiparametric image analysis to distinguish between cytosolic and nuclear HIF1 activities ( Figure   S1D ). Mean fluorescence intensities of HIF1 were higher in the nucleus than cytosolic levels, but we did not observe differences between WT and IRG1 -/-BMDMs (Figure S1E) . Mtb infection increased abundance of nuclear HIF1, again similarly in WT and IRG1 -/cells. Therefore, it is seemingly that the increased Mtb persistence/replication in IRG1 -/phagocytes in vitro is not a direct consequence of altered inflammatory and/or antimicrobial responses modulated by HIF1 activation.
Metabolite generation and host cell homeostasis are intimately connected and can affect outcome of immune responses. Previous observations have shown that Mtb persistence/replication relies on the availability of host nutrients that the bacteria exploit to build their replicative niche in phagocytes. In recent years, lipid droplets (LDs) were recognized as dynamic players of lipid metabolism and important regulators of immune cell function (den Brok et al. 2018) . During infection, the key carbon source for intracellular Mtb consists of host lipids that are mainly stored in LDs (Peyron et al. 2008) , and which are also responsible of the foamy phenotype of macrophages inside tuberculosis granuloma (Russell et al. 2009 ). Furthermore, the ESX-1 secretion system of Mtb was shown to interfere with host homeostasis and lipid metabolism favoring actively the formation of LDs in infected host cells (Singh et al. 2012) . Therefore, we investigated the impact of IRG1 deficiency on the formation of LDs and their availability in host cells during Mtb infection in vitro. We used a specific dye to label neutral LDs in BMDMs and BMDCs at 96 hpi, i.e. the time point where differences in Mtb replication rate were obvious (Figure 2B-C) . We again applied automated confocal microscopy and multiparametric image analysis to detect and quantify LDs in both cell types Next, we explored the physiological relevance of IRG1 deficiency during Mtb infection in vivo using an established infection model in C57BL/6 mice. A previous study demonstrated that, compared to WT mice, their IRG1 -/counterparts were more susceptible to aerosol infection with the Mtb Erdman strain (Nair et al. 2018) . Here, we comparatively evaluated, in WT and IRG1 -/mice, the impact of the intranasal inoculation of the high dose of 1 x 10 5 colony-forming units (CFU) per mouse of the virulent Mtb H37Rv strain or the attenuated M. bovis BCG Pasteur vaccinal strain 1173P2 (Figure 4A) . Body weight, mycobacterial burden and survival were thus monitored during the course of infection for at least 77 days post-infection (dpi). During the first two weeks post-infection, the body weight of WT and IRG1 -/mice, either infected with Mtb or BCG, did not show any difference. From 14 dpi onwards, IRG1 -/mice exposed to Mtb started to lose approximately one gram of body weight daily, while WT mice exposed to Mtb or BCG, as well as IRG1 -/mice exposed to BCG were not affected ( Figure 4B) . In contrast to the WT mice exposed to Mtb or BCG and the IRG1 -/mice exposed to BCG, which even until 77 dpi did not display loss in body weight nor morbidity or mortality, all Mtb-exposed IRG1 -/mice reached moribund conditions and died between 3 and 4 weeks post-infection ( Figure 4C) , similar to IRG1 -/mice infected by Mtb Erdman (Nair et al. 2018) , and confirming the substantial susceptibility of mice to Mtb infection in the absence of functional IRG1.
At 21 dpi, the lungs of Mtb-infected IRG1 -/mice were enlarged and displayed macroscopic pathological features with areas of necrotizing lesions (Figure 4D) . Histological examination of the lungs using hematoxylin phloxine saffron staining showed massive granulomatous inflammation in Mtb-exposed IRG1 -/mice compared to their WT counterparts (Figure 4E) . Ziehl-Neelsen staining of mycobacteria applied to the histological lung sections detected substantial amounts of invading Mtb in the lung parenchyma of IRG1 -/mice (Figure 4F , inset 2), while lungs of WT mice contained much lower numbers of Mtb (Figure 4F, inset 1) . Determination of mycobacterial loads at different time points post-infection demonstrated that while Mtb loads in the lung were comparable at the day of intranasal inoculation and during the first two weeks of the infection (7 dpi, 14 dpi), 20-fold more CFU were detected in the lungs of IRG1 -/mice (CFU mean: 58.0 x 10 6 ± 2.3 x 10 6 ) compared to WT mice (CFU mean: 2.8 x 10 6 ± 0.9 x 10 6 ) at 21 dpi (Figure 5A ). In addition, examination of tracheobronchial lymph node, spleen and liver showed Mtb dissemination from 7 dpi and/or 14 dpi onwards. In BCG-exposed WT and IRG1 -/mice, similar mycobacterial lung burdens were detected at 0 dpi and 7 dpi (Figure 5B) . At 14 dpi, BCG burden in the lungs of IRG1 -/mice was already higher than in WT controls. At the late time point of 86 dpi, only few amounts of residual BCG were still detectable in the lungs of WT mice, while IRG1 -/mice contained substantial amounts of BCG ( Figure 6A ). In accordance, BCG was still detectable even at 86 dpi at relatively high amounts in the trancheobronchial lymph nodes and livers of IRG1 -/mice. Altogether, these results indicate a major contribution of IRG1, and its catalytic product itaconate, in the antimicrobial host response not only at the mucosal site of infection but also systemically. Our observations in vivo clearly indicate that IRG1 -/mice are highly susceptible to virulent Mtb developing a severe phenotype leading to the death of all animals within 3-4 weeks. Infection of IRG1 -/mice with an attenuated mycobacterial strain (M. bovis BCG) leads to lower pathogenicity, but these mice still show a higher susceptibility compared to infected WT mice, and BCG mycobacteria are able to persist at high levels in these mice long after the exposure.
Finally, we performed immune cell characterization in WT and IRG1 -/mice during the entire Mtb infection period until 21 dpi by determining the total cell numbers of macrophages, eosinophils, DCs, neutrophils, CD4 + T cells, CD8 + T cells and B cells in lungs and spleen. Until 14 dpi, all lung and splenic cell populations were comparable between WT and IRG1 -/mice and did not show remarkable differences ( Figure 6A, Figure S2 ). In contrast, the time period between 14 dpi and 21 dpi led to a dramatic increase in pulmonary macrophages (both alveolar and interstitial ones) as well as neutrophils in the lungs of IRG1 -/mice, while levels of CD4 + T cells, CD8 + T cells and B cells were significantly decreased compared to WT mice (Figure 6A) . In the spleen, DCs and neutrophils were significantly increased in IRG1 -/mice at 21 dpi, while CD4 + T cells and B cells exhibited a reduction compared to WT cells (Figure S2) . These findings demonstrate that macrophages (in the lung), DCs (in the spleen) and neutrophils (in both organs) are the main cell populations that are responsible for the increased progression of Mtb infection in IRG1 -/mice. This is underlined by the fact that neutrophils in the lungs of IRG1 -/mice displayed a dramatically higher mycobacterial burden compared to lungs of their WT counterparts, when they were labeled in situ ( Figure   6B ). In line with this, the observed reduction in T cell and B cell levels in both, lung and spleen, of IRG1 -/-mice might suggest impaired adaptive immunity in those animals compared to Mtb-infected WT mice, which could be beneficial to Mtb progression and immunopathology observed in IRG1 -/animals. Altogether, our findings clearly indicate an important role of IRG1 in the immunometabolic host response to Mtb infection.
Discussion
The mammalian catalytic enzyme IRG1 and its generated metabolite itaconate are only induced during infection and/or inflammation (Basler et al. 2006 ) and were previously described for their antimicrobial activities (McKinney et al. 2000 , Michelucci et al. 2013 , Naujoks et al. 2016 , Nair et al. 2018 , Price et al. 2019 . In this study, we addressed the role of IRG1 in immunometabolic host responses during Mtb infection and were able to demonstrate that IRG1 is essential for the outcome of immunopathology, both in vitro and in vivo. Our findings showed that expression of IRG1 is induced during Mtb infection and controls the formation of LDs to restrict intracellular pathogen growth, which we have summarized in A previous study (Nair et al. 2018) investigating the impact of IRG1 on Mtb infection using the Erdman strain by aerosol inoculation showed similar susceptibility and immunopathological features of IRG1 -/mice with increased mycobacterial loads in lungs and spleen at 21 dpi. Importantly, we show here on the subcellular level, by applying automated confocal microscopy to macrophages and DCs, that this observation is a consequence of the uncontrolled generation of lipid droplets and increased mycobacterial replication in IRG1 -/phagocytes. Furthermore, we show here that the higher susceptibility of IRG1-deficient mice is not only specific to mycobacteria, but is also directly linked to the virulence of Mtb. Nair et al. showed that infection of mice by Listeria monocytogenes and influenza A virus did not result in altered susceptibility of IRG1 -/animals. In our study, we provide evidence that IRG1 -/mice are only highly susceptible to virulent Mtb but not to attenuated mycobacterial species, such as the vaccinal strain M. bovis BCG. Nonetheless, BCG-infected IRG1 -/mice displayed differences compared to BCG-infected WT mice, because mycobacteria were able to persist at higher levels in absence of IRG1 expression long after the initial exposure. Therefore, future work is needed to identify the factors that contribute to the link between pathogen virulence and susceptibility of IRG1-deficient animals.
For the first time, we could show in our study that IRG1 is recruited to Mtb-containing vacuoles, as it has been demonstrated previously for Legionella pneumophila-containing vacuoles (Naujoks et al. 2016) .
In both cases, pathogen growth is reduced indicating that presence of IRG1 in those vacuoles might lead to the local production of itaconate and generating an antimicrobial gradient in these cell organelles.
Another IFN-inducible protein has been identified in the past that localized to Mtb-containing vacuoles. The intracellular localization of Interferon-induced transmembrane protein 3 (IFITM3) overlapped with Mtb localized in late phagosomes, and IFITM3 overexpression was able to inhibit Mtb growth in human monocytes (Ranjbar et al. 2015) . Intriguingly, recent work investigating Pseudomonas aeruginosa infection showed that dysfunction in cystic fibrosis transmembrane conductance regulator (CFTR) stimulated mitochondrial activity and led to an anti-inflammatory host response controlled by IRG1 and itaconate leading to an inefficient clearance of this pathogen (Riquelme et al. 2019) . A bacterial killing capacity of CFTR has been described previously controlling phagosomal pH and phagolysosomal acidification (Di et al. 2006) and was shown to protect against Mycobacterium abscessus infection (Bernut et al. 2019 ). The block of phagosomal acidification and hydrolase activity induced by Mtb also requires the activity of ion channels (Sturgill-Koszycki et al. 1994; Wong et al. 2011; Queval et al. 2017; Buter et al. 2019) . Therefore, a likely scenario is that Mtb virulence factors, such as phoPR, interfere with chloride ion levels in host cells (Tan et al. 2013; Baker et al. 2019) to interfere with the antimicrobial activity of IRG, which needs to be addressed in future studies.
In our settings, IRG1 deficiency led to the increased formation of LDs during Mtb infection in macrophages and DCs. A previous study showed that LD formation is resulting from immune activation of macrophages as part of their host defense mechanism against Mtb infection and is not directly induced by the pathogen itself (Knight et al. 2018) . The authors showed that this HIF1-dependent signaling pathway, and its target gene Hig2, were required for the majority of LD formation in the lungs of Mtb-infected mice.
Our findings, on the other hand, suggest that increased LD generation in IRG1 -/phagocytes favors Mtb replication and growth indicating a dependence of this pathogen on host lipids stored in host LDs. Although our results excluded the direct participation of HIF1 in this process, since HIF1 expression and activation were not affected by IRG1 deficiency, future investigations need to rule out the divergent role of host enzymes involved in LD biogenesis, such as DGAT1 and DGAT2, in this process (Bhatt-Wessel et al. 2018) .
Changes in available host lipids also have direct consequences on the modulation of adaptive immune responses. For example, LD generation was correlated to efficacy and regulation of cross-presentation pathways (Bougnères et al. 2009 ), which include exogenous antigens derived from Mtb infection. In addition, Mtb virulence factors were shown to interfere with LD formation (Elamin et al. 2011) . Our observations that IRG1 deficiency induced a severe reduction in T and B cell compartments in Mtb-infected lungs and spleens, further emphasizes the role of players of adaptive immunity in the progression of Mtb immunopathologies and requires further investigation. Overall, we could show in our study that immunometabolic host responses during Mtb infection are essential to control infection outcome and immunopathology. IRG1 expression and itaconate production are one of the key nodes that determine efficient host immunity in TB suggesting that their modulation might be used in the future development of HDTs to improve immunometabolic host responses to Mtb infection.
Material and Methods
Mice. C57BL/6NJ wild type mice and C57BL/6NJ-Acod1 em1(IMPC)J /J (IRG1 -/-) mice deficient in Irg1 After 7 days incubation at 37°C in an atmosphere containing 5% CO2, the BMDM monolayer was rinsed with D-PBS and cells harvested with Versene (Gibco). BMDC were differentiated as previously described (Alloatti et al., 2015) . Briefly, 2x10 7 murine bone marrow progenitors were seeded in 100 ml RPMI-FBS supplemented with 10% J558-conditioned medium containing Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) in 500 cm 2 square petri dishes (Nunc). Cells were incubated at 37°C in 5% CO2. Fresh medium was added every 3-4 days. On day 10, the supernatant was discarded and adherent cells were harvested using DPBS containing 2 mM EDTA (Sigma-Aldrich). BMDM and BMDC were resuspended into corresponding culture medium to be used for subsequent assays. 
Bacteria. Recombinant strains of

Infection for intracellular mycobacterial replication and Lipid Droplets (LDs) formation assays. 2x10 4
BMDM or 4x10 4 BMDC were seeded per well in 384-well plates. After 12 hours incubation at 37°C with 5% CO2, LPS (100 ng/mL) and IFN-gamma (50 ng/mL) were added as positive control. After overnight incubation, cells were infected for 2 h with H37Rv-GFP at a MOI of 1. Cells were washed with RPMI-FBS and treated with amikacin (50 µg/mL) for 1 h in order to remove extracellular Mtb. Then, cells were washed twice with RPMI-FBS and incubated at 37°C with 5% CO2.
For intracellular mycobacterial replication assay, 10% formalin solution (Sigma-Aldrich) containing 10 µg/mL Hoechst 33342 (Life-Technologies) was replaced to each well at 2 h and 96 h post-infection.
Plates were incubated at RT for 30 min, allowing staining and cell fixation. Cells were stored in DPBS supplemented with 1% FBS, until image acquisition.
For LD formation assay, cells were washed and fixed at 96 h post-infection, as previously described.
Cells were washed twice with DBPS and intracellular LDs were stained with 25 µL per well of 2000-fold diluted HCS LipidTOX deep Red neutral lipid probe (Invitrogen) in PBS for 30 min at room temperature. Image Acquisition. Image acquisitions were performed on an automated confocal microscope (Opera, PerkinElmer) using a 20x and 60x water objectives for intracellular mycobacterial replication and LD formation assays, respectively. The microscope was equipped with 405 nm, 488 nm, 561 nm and 640 nm excitation lasers. The emitted fluorescence was captured using three cameras associated with a set of filters covering a detection wavelength ranging from 450 nm to 690 nm. Hoechst 33342-stained nuclei were detected using the 405 nm laser with a 450/50-nm emission filter. Green or red signals, corresponding to H37Rv-GFP and H37Rv-DsRed, were recorded using 488 nm or 561 nm lasers with 540/75-or 600/40-nm emission filters, respectively. LipidTOX signal was detected using 630-nm excitation and 690-nm emission wavelengths.
Image-based analysis. For mycobacteria replication and LD generation quantification, images from the automated confocal microscope were analyzed using multi-parameter scripts developed using Columbus system (version 2.3.1; PerkinElmer) ( Supplementary Tables 2 and 3) .
Cell detection and M. tuberculosis intracellular replication
Segmentation algorithms were applied to input images to detect nuclei labeled by Hoechst 33342 (cyan) and the GFP signal of Mtb H37Rv (green) to determine infection and replication rates. Briefly, the host cell segmentation was performed using two different Hoechst signal intensities-a strong intensity corresponding to the nucleus and a weak intensity in cytoplasm-with the algorithm "Find Nuclei" and "Find Cytoplasm", as described previously . GFP or DsRed signal intensities in a cell were used for the intracellular bacterial segmentation with the algorithm "Find Spots". The identified intracellular bacteria were quantified as intracellular Mtb area with number of pixels. Subsequently, population of infected cells was determined, and the increase of intracellular Mtb area, corresponding to intracellular mycobacterial replication, was calculated.
Cell detection and quantification of LD formation
LDs labeled by LipidTox DeepRed (red), nuclei labeled by Hoechst 33342 (blue) and the GFP signal of Mtb H37Rv (green) were detected using segmentation algorithms applied to input image. Briefly, the host cell segmentation using Hoechst signal and LipidTox intensities was performed to detect nuclei and cell borders, respectively. Mtb and LDs were determined by applying masks, which were adapted to GFP and LipidTox dye signal intensities, respectively. Further filtering and refinement using the algorithm "Find Micronuclei" and based on size-to-signal intensity and area of LD candidates allowed specific selection of LDs, which were separated from out-of-focus and background signal intensities. The identified intracellular bacteria were quantified as intracellular Mtb area with number of pixels. Subsequently, population of infected (Mtb) and non-infected (NI) cells were determined, and the percentage of LD-positive cells and the average of LD number per cell were calculated.
Western Blotting. Latex bead-containing phagosomes (LBPs) were isolated as described previously (Pauwels et al. 2019) . LBP pellets were lysed in 2% (v/v) Triton X-100, 50 mM Tris, pH 8.0, 10 mM dithiothreitol, 2x protease inhibitor mixture (Roche, France) for 30 min on ice. Phagosomal lysates and total cell lysates (TCL) were mixed with 5x Laemmli sample buffer and boiled for 5 min at 95 °C. Samples were loaded on 4-15% Criterion TGX protein gels (Bio-Rad, USA) and run in 25 mM Tris, 192 mM glycine, 0.1% (m/vol) SDS, pH 8.3, at 100 V. Proteins were transferred onto 0.2 µm PVDF membranes by a Trans-Blot Turbo device (Bio-Rad, USA) at 2.5 A for 7 min. Equal loading of samples was controlled by Ponceau S staining. After transfer, membranes were blocked in 5% dry milk and incubated with primary antibodies and peroxidase-conjugated secondary antibodies. Bound antibodies were revealed using Chemiluminescence Blotting Substrate from Roche according to the manufacturers' directions.
Immunofluorescence. BMDMs were grown overnight on poly-L-lysine-coated glass coverslips the day before the infection. Cells were infected with Mtb H37Rv-DsRed at an MOI = 1 for 24 h. Subsequently, cells were washed three times with PBS and fixed in PBS + 4% paraformaldehyde + 4% sucrose, pH 7.4, for 20 min at RT followed by quenching in PBS + 50 mM NH4Cl for 10 min. Coverslips were labeled for IRG1 (Abcam, UK), DNA using DAPI (Sigma-Aldrich, USA) and F-actin using Alexa Fluor 680 phalloidin (ThermoFisher, USA). After extensive washing, the coverslips were post-fixed in 4% paraformaldehyde for 16 h and then mounted with ProLong Gold antifade reagent (ThermoFisher, USA). Images were acquired using a confocal microscope (Zeiss LSM880) equipped with a 63x objective (NA 1.4) and Zen imaging software (Zeiss, Germany).
Quantitative RT-PCR. BMDMs were grown in 6-well plates and RNA was isolated using the RNeasy Mini kit (Qiagen, Germany) following the manufacturer's instructions. RNA concentration was determined using the GE SimpliNano device (GE Healthcare, UK). Remaining DNA in samples was digested using the amplification grade DNase I kit (Sigma-Aldrich, USA) for 6 min at RT. The reaction was stopped by heat inactivation for 10 min at 70°C. cDNA synthesis was achieved by reverse transcription using the SuperScript VILO kit (ThermoFisher, USA) following the manufacturer's instructions. qPCR was performed using the LightCycler 480 SYBR Green I reagent (Roche, France) with 20 ng cDNA per sample and the indicated primer pairs ( Supplementary Table S1 ). qPCR reactions were measured by the QuantStudio 12K Flex system (Applied Biosystems, USA) using the following cycles: 2 min 50°C, 10 min 95°C followed by 40 cycles of 15 s 95°C, 30 s 60°C and 30 s 72°C. Haan, Germany). Ten-fold serial dilutions (from 10 -2 to 10 -9 ) of each sample were plated onto 7H11 medium agar plate (Difco) supplemented with 10% oleic acid-albumin-dextrose-catalase (OADC, Difco). After a three-week growth period at 37°C, CFUs were determined at the appropriate dilution allowing optimal colonies enumeration.
Histology by immunofluorescence. As described previously (Machelart et al. 2019) , lungs were perfused and fixed overnight at 4°C with 10 % neutral buffered Formalin solution (Sigma-Aldrich), washed in PBS, and incubated overnight at RT in a 20 % PBS-sucrose solution. Tissues were then embedded in the Tissue-
Tek OCT compound (Sakura), frozen in liquid nitrogen, and cryostat sections (10 μm) were prepared. 
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